Publications by authors named "Lee Funk"

Claim this Profile
S
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK).
J Jean Cui, Michelle Tran-Dubé, Hong Shen, Mitchell Nambu, Pei-Pei Kung, Lee Funk

J Med Chem· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore.
Fraser F Fleming, Lihua Yao, P C Ravikumar, Lee Funk, Brian C Shook

J Med Chem· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone.
Pei-Pei Kung, Lee Funk, Jerry Meng, Michael Collins, Joe Zhongxiang Zhou

Bioorg Med Chem Lett· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure activity relationships of quinoline-containing c-Met inhibitors.
Pei-Pei Kung, Lee Funk, Jerry Meng, Gordon Alton, Ellen Padrique

Eur J Med Chem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of HCV NS5B polymerase. Part 2: Evaluation of the northern region of (2Z)-2-benzoylamino-3-(4-phenoxy-phenyl)-acrylic acid.
Jeffrey A Pfefferkorn, Richard Nugent, Rebecca J Gross, Meredith Greene, Mark A Mitchell, Lee A Funk

Bioorg Med Chem Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic alkenenitriles: chemoselective oxonitrile cyclizations.
Fraser F Fleming, Lee A Funk, Ramazan Altundas, Vaqar Sharief

J Org Chem· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis